1. Butylphthalide is effective — the BAST trial showed that butylphthalide is associated with more favorable functional outcomes compared to placebo in patients who underwent reperfusion therapy for acute ischemic stroke. 2. Butylphthalide is safe – the treatment and placebo group had similar incidences of serious adverse outcomes (death, symptomatic intracranial hemorrhage and other side